AMOROSO, VITO
 Distribuzione geografica
Continente #
NA - Nord America 3.324
AS - Asia 1.723
EU - Europa 1.633
SA - Sud America 320
AF - Africa 33
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.046
Nazione #
US - Stati Uniti d'America 3.251
SG - Singapore 694
CN - Cina 478
DE - Germania 423
IT - Italia 322
BR - Brasile 266
UA - Ucraina 167
HK - Hong Kong 154
FI - Finlandia 145
VN - Vietnam 141
RU - Federazione Russa 134
GB - Regno Unito 106
PL - Polonia 83
FR - Francia 75
TR - Turchia 62
IN - India 57
CA - Canada 45
IE - Irlanda 40
CZ - Repubblica Ceca 31
BD - Bangladesh 28
SE - Svezia 25
ID - Indonesia 22
AR - Argentina 21
NL - Olanda 19
MX - Messico 17
ES - Italia 14
ZA - Sudafrica 14
BE - Belgio 13
IQ - Iraq 13
JP - Giappone 11
UZ - Uzbekistan 10
AU - Australia 9
EC - Ecuador 9
PK - Pakistan 8
CH - Svizzera 7
PY - Paraguay 7
AT - Austria 6
CO - Colombia 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
SA - Arabia Saudita 5
CL - Cile 4
EE - Estonia 4
ET - Etiopia 4
JO - Giordania 4
PH - Filippine 4
AM - Armenia 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
LV - Lettonia 3
MA - Marocco 3
NG - Nigeria 3
PA - Panama 3
RO - Romania 3
VE - Venezuela 3
AZ - Azerbaigian 2
CR - Costa Rica 2
DZ - Algeria 2
GR - Grecia 2
IR - Iran 2
LB - Libano 2
NP - Nepal 2
PE - Perù 2
TW - Taiwan 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
FK - Isole Falkland (Malvinas) 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.046
Città #
Fairfield 357
Singapore 347
Ashburn 334
Woodbridge 240
Houston 161
San Jose 154
Hong Kong 153
Seattle 136
Cambridge 135
Jacksonville 131
Chandler 123
The Dalles 114
Wilmington 114
Ann Arbor 110
Beijing 109
New York 98
Helsinki 93
Dallas 82
Warsaw 81
Munich 68
Los Angeles 66
Princeton 65
Istanbul 47
Lauterbourg 45
Ho Chi Minh City 44
Dublin 40
Boardman 38
Dearborn 37
Milan 34
Brescia 33
Council Bluffs 33
Turku 32
Redondo Beach 31
Nanjing 28
Shanghai 28
Orem 26
Chicago 25
Moscow 25
Brno 22
Hanoi 22
Rome 22
Changsha 20
London 20
Nuremberg 20
Nürnberg 20
Stockholm 20
São Paulo 20
Des Moines 16
Nanchang 16
San Francisco 16
Santa Clara 16
Montreal 15
Jakarta 14
Mumbai 14
Toronto 13
Brooklyn 12
Brussels 12
Buffalo 12
Poplar 12
Atlanta 11
Chennai 11
Hebei 11
Rio de Janeiro 11
San Diego 11
Shenyang 11
Tokyo 11
Bergamo 10
Dalmine 10
Jinan 10
Mexico City 10
Romola 10
Denver 9
Lappeenranta 9
Tashkent 9
Tianjin 9
Belo Horizonte 8
Guangzhou 8
Haiphong 8
Jiaxing 8
Johannesburg 8
Olomouc 8
Amsterdam 7
Boston 7
Campinas 7
Hangzhou 7
Salt Lake City 7
San Mateo 7
Washington 7
Baghdad 6
Buenos Aires 6
Frankfurt am Main 6
Naples 6
Ningbo 6
Paris 6
Biên Hòa 5
Charlotte 5
Da Nang 5
Dietikon 5
Manchester 5
Orange 5
Totale 4.497
Nome #
Excess of second tumors in denosumab-treated patients: A metabolic hypothesis 246
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 211
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 208
Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials 208
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 196
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 195
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 192
Regression of advanced neuroendocrine tumors among patients receiving placebo 187
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 180
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 179
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies. 176
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 172
Adjuvant bisphosphonates in patients with breast cancer: Does the potency matter? 172
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 172
Serum vitamin D and prostate cancer prognosis: The story continues 167
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 167
Exemestane with ovarian suppression in premenopausal breast cancer. 166
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 165
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 165
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 152
The involvement of early stage breast cancer patients during oncology consultations in Italy: a multi-centred, randomized controlled trial of a Question Prompt Sheet versus Question Listing 151
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 149
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 147
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 143
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 134
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 131
Management of neuroendocrine tumors: State of the art 127
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis 127
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 127
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 122
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 118
The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy 117
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 113
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 112
Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world data 111
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 104
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 102
Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view 97
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 97
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 95
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 94
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 92
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 88
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 87
Endocrine and Neuroendocrine Tumors: A Special Issue 83
Adjuvant denosumab for early breast cancer-Evidence and controversy 81
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (carcinoid): Results from the Phase 2 ATLANT Study 78
Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma 74
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 73
Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria 71
Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study 65
Regression of advanced neuroendocrine tumors among patients receiving placebo 54
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET) 33
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective study 30
Selpercatinib plus cemiplimab in RET positive medullary thyroid cancer patient with skin cancers 29
Totale 7.132
Categoria #
all - tutte 31.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021166 0 0 0 0 0 0 0 0 0 69 69 28
2021/2022303 40 24 17 10 4 20 3 29 13 35 18 90
2022/2023364 39 10 9 22 35 87 3 31 59 13 36 20
2023/2024491 32 13 50 22 26 78 17 21 92 11 12 117
2024/20251.213 15 13 14 213 114 83 98 45 194 75 206 143
2025/20262.387 219 301 228 360 270 223 356 100 161 169 0 0
Totale 7.132